Filing Details

Accession Number:
0001209191-23-005671
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-31 15:42:00
Reporting Period:
2023-01-26
Accepted Time:
2023-01-31 15:42:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1231457 Genelux Corp GNLX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1937484 Qian Zhang C/O Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village CA 91361
Associate Vp, Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-26 200 $6.25 200 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 133,333 Direct
Footnotes
  1. Shares held by Liu-Zhang Trust.